{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02127710",
      "OrgStudyIdInfo": {
        "OrgStudyId": "D5082C00002"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "GU 111",
            "SecondaryIdType": "Other Identifier",
            "SecondaryIdDomain": "Sarah Cannon Research Institute (SCRI)"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "AstraZeneca",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)",
      "OfficialTitle": "A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2021",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 30, 2014",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "April 14, 2016",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 20, 2020",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "April 23, 2014",
      "StudyFirstSubmitQCDate": "April 28, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "May 1, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "ResultsFirstSubmitDate": "September 13, 2017",
      "ResultsFirstSubmitQCDate": "September 13, 2017",
      "ResultsFirstPostDateStruct": {
        "ResultsFirstPostDate": "October 12, 2017",
        "ResultsFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "March 23, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 19, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "AstraZeneca",
        "LeadSponsorClass": "INDUSTRY"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "SCRI Development Innovations, LLC",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This is an open-label, single-arm, multicentre, global, phase II study designed to evaluate the efficacy and safety of AZD6094 in patients with papillary renal cell carcinoma (PRCC) who are treatment naïve or previously treated.\n\nAn independent central pathology review of tumour samples will be used to confirm the diagnosis of PRCC of all patients enrolling. However, locally available pathology results confirming PRCC will be allowed for timely study entry.",
      "DetailedDescription": "The study will comprise two stages. In Stage 1 approximately 20 patients will be enrolled. This group is considered sufficient to provide preliminary assessment of the anti-tumour activity of AZD6094 in the form of non-binding futility analysis.\n\nIf ≤ 2 tumour responses are observed in the first 20 evaluable patients termination of the study will be considered taking into account the relevant molecular profile of the patients and additional information from related studies in the drug development programme.\n\nAll patients entering the study will take AZD6094 600 mg by mouth (PO) once daily (QD). Treatment will be given continuously.\n\nFollowing the baseline assessment, efficacy will be assessed by objective tumour assessments every 6 weeks (±7 days), for the first 12 months and every 12 weeks thereafter until objective disease progression as defined by RECIST v1.1 There will be a data cut-off after all patients have completed at least 12 weeks of treatment with AZD6094 or withdrawn. The database will be locked and data analysis will be performed on this dataset.\n\nAny patients still receiving study drug at the time of data cut-off will be able to continue to receive AZD6094 while deriving clinical benefit. Such patients will continue to be monitored for the occurrence of serious adverse events up to 28 days after the last dose of AZD6094.\n\nAfter database lock (DBL) tumour assessments will be performed every 12 weeks (±7 days) until objective disease progression as defined by RECIST v1.1.\n\nPatients discontinuing treatment due to documented disease progression will enter a survival follow-up period, where they will be followed for the initiation of subsequent anti-cancer therapies every 3 months until death, loss to follow-up or withdrawal of consent, whichever comes first.\n\nPatients discontinuing treatment prior to documented disease progression will enter a progression-free survival follow-up period where they will continue to have disease assessments every 6 weeks (±7 days) for the first 12 months of follow-up and every 12 weeks thereafter until objective disease progression as defined by RECIST v1.1, death, loss to follow-up or withdrawal of consent, whichever comes first. After DBL, tumour assessments will be performed in the progression free survival patient population every 12 weeks (±7 days) until objective disease progression as defined by RECIST v1.1"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Papillary Renal Cell Cancer"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "AZD6094",
          "Savolitinib",
          "Papillary Renal Cell Cancer"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "111",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "AZD6094 600 mg daily continuously",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "All patients entering the study will take AZD6094 600 mg by mouth (PO) once daily (QD). Treatment will be given continuously.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: AZD6094"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "AZD6094",
            "InterventionDescription": "AZD6094 is a potent and selective small molecule mesenchymal epithelial transition (c-MET) kinase inhibitor.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "AZD6094 600 mg daily continuously"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Savolitinib",
                "HMPL - 504"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Objective Response Rate (RECIST Version 1.1)",
            "PrimaryOutcomeDescription": "The primary outcome measure was Objective Response Rate (ORR), defined as the proportion of patients with either a complete response or a partial response by investigator assessment according to Response Evaluation Criteria for Solid Tumours (RECIST) v1.1.",
            "PrimaryOutcomeTimeFrame": "Up to 12 months"
          },
          {
            "PrimaryOutcomeMeasure": "Objective Response Rate (RECIST Version 1.1) Stratified by c-MET Status in Efficacy Analysis Set",
            "PrimaryOutcomeDescription": "The primary outcome measure was ORR, defined as the proportion of patients with either a complete response or a partial response by investigator assessment according to RECIST v1.1.",
            "PrimaryOutcomeTimeFrame": "12 Months"
          },
          {
            "PrimaryOutcomeMeasure": "Objective Response Rate (RECIST Version 1.1) Stratified by c-MET Status in Safety Analysis Set",
            "PrimaryOutcomeDescription": "The primary outcome measure was ORR, defined as the proportion of patients with either a confirmed complete response/partial response by investigator assessment according to RECIST v1.1.",
            "PrimaryOutcomeTimeFrame": "12 Months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Progression Free Survival Stratified by c-MET Status in the Efficacy Analysis Set",
            "SecondaryOutcomeTimeFrame": "Up to 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Overall Survival Stratified by c-MET Status in the Efficacy Analysis Set",
            "SecondaryOutcomeTimeFrame": "Up to 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Progression Free Survival Stratified by c-MET Status in the Safety Analysis Set",
            "SecondaryOutcomeTimeFrame": "Up to 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Overall Survival Stratified by c-MET Status in the Safety Analysis Set",
            "SecondaryOutcomeTimeFrame": "Up to 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Change From Baseline in Target Lesion Tumour Size at 12 Weeks in Efficacy Analysis Set",
            "SecondaryOutcomeDescription": "12 week summary for patients in the Efficacy analysis set, by MET status. The numbers of patients analysed represent the numbers evaluable at the 12 week timepoint.",
            "SecondaryOutcomeTimeFrame": "12 Weeks (at 12 weeks timepoint)"
          },
          {
            "SecondaryOutcomeMeasure": "Change From Baseline in Target Lesion Tumour Size at 12 Weeks in Safety Analysis Set.",
            "SecondaryOutcomeDescription": "12 week summary for patients in the Safety analysis set by MET Status. The number of patients analysed represent the number of evaluable patients at the 12 week timepoint.",
            "SecondaryOutcomeTimeFrame": "12 Weeks (at 12 week timepoint)"
          },
          {
            "SecondaryOutcomeMeasure": "Duration of Response",
            "SecondaryOutcomeDescription": "Duration of Response is the time from the first documentation of confirmed complete response/partial response until the date of progression, or death in the absence of progression. There were 8 responders: one of whom subsequently progressed or died and seven of whom were still classified as responders at the time of data cut-off and were therefore censored. It was not possible to determine a median or 75th percentile.",
            "SecondaryOutcomeTimeFrame": "Up to 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Peak Plasma Concentration of AZD6094 Following Single Dose",
            "SecondaryOutcomeDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "SecondaryOutcomeTimeFrame": "24 Hours"
          },
          {
            "SecondaryOutcomeMeasure": "Time to Peak Plasma Concentration of AZD6094 After Single Dose",
            "SecondaryOutcomeDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "SecondaryOutcomeTimeFrame": "24 Hours"
          },
          {
            "SecondaryOutcomeMeasure": "Apparent Volume of Distribution of AZD6094 Following Single Dose",
            "SecondaryOutcomeDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "SecondaryOutcomeTimeFrame": "24 Hours"
          },
          {
            "SecondaryOutcomeMeasure": "Area Under Plasma Concentration Time Curve for AZD6094 After Single Dose",
            "SecondaryOutcomeDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "SecondaryOutcomeTimeFrame": "24 Hours"
          },
          {
            "SecondaryOutcomeMeasure": "Area Under Plasma Concentration Time Curve for AZD6094 After Single Dose (Time Zero to Last Measurement)",
            "SecondaryOutcomeDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "SecondaryOutcomeTimeFrame": "24 Hours"
          },
          {
            "SecondaryOutcomeMeasure": "Apparent Total Clearance of AZD6094 From Plasma After Single Dose",
            "SecondaryOutcomeDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "SecondaryOutcomeTimeFrame": "24 Hours"
          },
          {
            "SecondaryOutcomeMeasure": "Mean Residence Time of AZD6094 After Single Dose",
            "SecondaryOutcomeDescription": "The number of patients analysed represent the number of evaluable PK parameters for this endpoint.",
            "SecondaryOutcomeTimeFrame": "24 Hours"
          },
          {
            "SecondaryOutcomeMeasure": "Elimination Half-Life of AZD6094 After Single Dose",
            "SecondaryOutcomeDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "SecondaryOutcomeTimeFrame": "24 Hours"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion criteria\n\nProvision of informed consent prior to any study specific procedures, sampling and analyses.\nHistologically confirmed PRCC, which is locally advanced or metastatic.\nAvailability of an archival tumor sample or a pre-treatment fresh tumor sample for confirmation of PRCC by a central laboratory and other biomarker\nTreatment naïve or have failed on previous treatment for PRCC. Previous treatments may include: targeted therapy (i.e. sunitinib, sorafenib, bevacizumab, pazopanib, temsirolimus, and everolimus), traditional immunotherapy (i.e. interferon-a, Interleukin-2), chemotherapy or a combination of chemoimmunotherapy.\nEastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.\nAt least one lesion, not previously irradiated, and not chosen for a biopsy if performed during the screening period that can be accurately measured at baseline and which is suitable for accurate repeated measurements.\n\nAdequate hematological function defined as:\n\nAbsolute neutrophil count ≥1500/μL\nHaemoglobin ≥9 g/dL\nPlatelets ≥100,000/μL\n\nAdequate liver function defined as:\n\nAlanine aminotransferase and aspartate aminotransferase ≤2.5 x the upper limit of normal (ULN)\nTotal bilirubin ≤1.5 x ULN\nAdequate renal function defined as glomerular filtration rate ≥ 40 mL/min,\nAdequate coagulation parameters, defined as International Normalisation Ratio <1.5 x ULN or activated partial thromboplastin time <1.5 x ULN.\nPatients with known tumor thrombus or deep vein thrombosis are eligible if stable on low molecular weight heparin for ≥4 weeks.\nFemales should be using adequate contraceptive measures should not be breast feeding, and must have a negative pregnancy test prior to start of dosing if of childbearing potential or must have evidence of non-childbearing potential\nMale patients should be willing to use barrier contraception, i.e. condoms.\nAbility to swallow and retain oral medications.\nPredicted life expectancy ≥12 weeks.\nAged at least 18 years.\nWillingness and ability to comply with study and follow-up procedures.\nAbility to understand the nature of this study and give written informed consent.\n\nExclusion criteria\n\nMost recent chemotherapy, immunotherapy, chemo-immunotherapy, or investigational agents <21 days of the first dose of study treatment. Most recent targeted therapy <14 days of the first dose of study treatment.\nUnresolved toxicities from any prior therapy greater than Common Terminology Criteria for Adverse Events Grade 1 at the time of starting study treatment with the exception of alopecia.\nPrior or current treatment with a cMet inhibitor\nStrong inducers or inhibitors of cytochrome P450 3A4 (CYP3A4), strong inhibitors of cytochrome P450 1A2 (CYP1A2), or CYP3A4 substrates with a narrow therapeutic range within 2 weeks before the first dose of study treatment (3 weeks for St John's Wort)\nWide field radiotherapy (including therapeutic radioisotopes such as strontium-89) administered ≤28 days or limited field radiation for palliation ≤7 days prior to starting study drug or has not recovered from side effects of such therapy\nMajor surgical procedures ≤28 days of beginning study drug or minor surgical procedures ≤7 days. No waiting is required following port-a-cath placement.\nPreviously untreated brain metastases.\nCurrent leptomeningeal metastases or spinal cord compression due to disease.\nAcute or chronic liver or pancreatic disease.\nUncontrolled diabetes mellitus.\nGastrointestinal disease or other condition that will interfere significantly with the absorption, distribution, metabolism, or excretion of oral therapy\n\nAny of the following cardiac diseases currently or within the last 6 months:\n\nUnstable angina pectoris\nCongestive heart failure (New York Heart Association ≥ Grade 2)\nAcute myocardial infarction\nStroke or transient ischemic attack\nInadequately controlled hypertension (i.e., systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg) (patients with values above these levels must have their blood pressure controlled with medication prior to starting treatment).\nMean resting correct QT interval (QTc) >470 msec obtained from triplicate electrocardiagrams\nAny clinically important abnormalities in rhythm, conduction or morphology of resting electrocardiograms, e.g. complete left bundle branch block, third degree heart block, second degree heart block, PR interval >250 msec.\nAny factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, hypokalaemia, congenital or familial long QT syndrome or family history of unexplained sudden death under 40 years of age or any concomitant medications known to prolong QT interval.\nCurrently receiving treatment with therapeutic doses of warfarin sodium. Low molecular weight heparin is allowed.\nSerious active infection at the time of treatment, or another serious underlying medical condition that would impair the ability of the patient to receive protocol treatment.\nKnown diagnosis of human immunodeficiency virus, hepatitis B, or hepatitis C.\nPresence of other active cancers, or history of treatment for invasive cancer ≤5years. Patients with Stage I cancer who have received definitive local treatment at least 3 years previously, and are considered unlikely to recur are eligible. All patients with previously treated in situ carcinoma (i.e., non-invasive) are eligible, as are patients with history of non-melanoma skin cancer.\nPsychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "99 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Henrik-Tobias Arkenau, MD,PhD",
            "OverallOfficialAffiliation": "Sarah Cannon Research Institute United Kingdom",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Birmingham",
            "LocationState": "Alabama",
            "LocationZip": "35294",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Duarte",
            "LocationState": "California",
            "LocationZip": "91010",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Palo Alto",
            "LocationState": "California",
            "LocationZip": "94305",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Fort Myers",
            "LocationState": "Florida",
            "LocationZip": "33916",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Chicago",
            "LocationState": "Illinois",
            "LocationZip": "60637",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Iowa City",
            "LocationState": "Iowa",
            "LocationZip": "52242",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Boston",
            "LocationState": "Massachusetts",
            "LocationZip": "02215",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Detroit",
            "LocationState": "Michigan",
            "LocationZip": "48201",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "New York",
            "LocationState": "New York",
            "LocationZip": "10021",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Philadelphia",
            "LocationState": "Pennsylvania",
            "LocationZip": "19111",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Nashville",
            "LocationState": "Tennessee",
            "LocationZip": "37203",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Dallas",
            "LocationState": "Texas",
            "LocationZip": "75246",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Houston",
            "LocationState": "Texas",
            "LocationZip": "77030",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Calgary",
            "LocationState": "Alberta",
            "LocationZip": "T2N 4N2",
            "LocationCountry": "Canada"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Edmonton",
            "LocationState": "Alberta",
            "LocationZip": "T6G 1Z2",
            "LocationCountry": "Canada"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Toronto",
            "LocationState": "Ontario",
            "LocationZip": "M4N 3M5",
            "LocationCountry": "Canada"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Toronto",
            "LocationState": "Ontario",
            "LocationZip": "M5G 2M9",
            "LocationCountry": "Canada"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Barcelona",
            "LocationZip": "08041",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Cambridge",
            "LocationZip": "CB2 0QQ",
            "LocationCountry": "United Kingdom"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Glasgow",
            "LocationZip": "G12 OYN",
            "LocationCountry": "United Kingdom"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "London",
            "LocationZip": "EC1M 6BQ",
            "LocationCountry": "United Kingdom"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "London",
            "LocationZip": "W1G 6AD",
            "LocationCountry": "United Kingdom"
          },
          {
            "LocationFacility": "Research Site",
            "LocationCity": "Manchester",
            "LocationZip": "M20 4BX",
            "LocationCountry": "United Kingdom"
          }
        ]
      }
    },
    "ReferencesModule": {
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "D5082c00002-revised-csp-3_Redacted",
            "SeeAlsoLinkURL": "http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=2609&filename=d5082c00002-revised-csp-3_Redacted.pdf"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Yes",
      "IPDSharingDescription": "Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All request will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
      "IPDSharingInfoTypeList": {
        "IPDSharingInfoType": [
          "Study Protocol",
          "Statistical Analysis Plan (SAP)"
        ]
      },
      "IPDSharingTimeFrame": "AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
      "IPDSharingAccessCriteria": "When a request has been approved AstraZeneca will provide access to the de-identified individual patient-level data in an approved sponsored tool . Signed Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access. For additional details, please review the Disclosure Statements at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
      "IPDSharingURL": "https://astrazenecagroup-dt.pharmacm.com/DT/Home"
    }
  },
  "ResultsSection": {
    "ParticipantFlowModule": {
      "FlowPreAssignmentDetails": "All patients were required to provide an archived or fresh tumour sample at enrolment to confirm eligibility, and for performance of the c-MET biomarker analysis. c-MET biomarker results determined the subgroup placement for data analysis as follows: c-MET positive (n=46), c-MET negative (n=47), and c-MET unknown (n=16).",
      "FlowRecruitmentDetails": "111 patients were enrolled; 109 patients received at least one dose of AZD6094 administered orally (po). Two patients withdrew prior to receiving any study drug. The study was conducted at 23 international sites in the United States, Canada, United Kingdom and Spain.",
      "FlowGroupList": {
        "FlowGroup": [
          {
            "FlowGroupId": "FG000",
            "FlowGroupTitle": "c-MET Positive [600mg AZD6094 po]",
            "FlowGroupDescription": "All participants tested for the presence of c-MET mutations"
          },
          {
            "FlowGroupId": "FG001",
            "FlowGroupTitle": "c-MET Negative [600mg AZD6094 po]",
            "FlowGroupDescription": "All participants were tested for the presence of c-MET mutations."
          },
          {
            "FlowGroupId": "FG002",
            "FlowGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
            "FlowGroupDescription": "All participants were tested for the presence of c-MET mutations."
          }
        ]
      },
      "FlowPeriodList": {
        "FlowPeriod": [
          {
            "FlowPeriodTitle": "Overall Study",
            "FlowMilestoneList": {
              "FlowMilestone": [
                {
                  "FlowMilestoneType": "STARTED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "46"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "47"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "16"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "46"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "47"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "16"
                      }
                    ]
                  }
                },
                {
                  "FlowMilestoneType": "NOT COMPLETED",
                  "FlowAchievementList": {
                    "FlowAchievement": [
                      {
                        "FlowAchievementGroupId": "FG000",
                        "FlowAchievementNumSubjects": "0"
                      },
                      {
                        "FlowAchievementGroupId": "FG001",
                        "FlowAchievementNumSubjects": "0"
                      },
                      {
                        "FlowAchievementGroupId": "FG002",
                        "FlowAchievementNumSubjects": "0"
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "BaselineCharacteristicsModule": {
      "BaselinePopulationDescription": "All subjects who received at least one dose of AZD6094 are included in the baseline analysis.",
      "BaselineGroupList": {
        "BaselineGroup": [
          {
            "BaselineGroupId": "BG000",
            "BaselineGroupTitle": "c-MET Positive [600mg AZD6094 po]",
            "BaselineGroupDescription": "All participants tested for the presence of c-MET mutations"
          },
          {
            "BaselineGroupId": "BG001",
            "BaselineGroupTitle": "c-MET Negative [600mg AZD6094 po]",
            "BaselineGroupDescription": "All participants were tested for the presence of c-MET mutations."
          },
          {
            "BaselineGroupId": "BG002",
            "BaselineGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
            "BaselineGroupDescription": "All participants were tested for the presence of c-MET mutations."
          },
          {
            "BaselineGroupId": "BG003",
            "BaselineGroupTitle": "Total",
            "BaselineGroupDescription": "Total of all reporting groups"
          }
        ]
      },
      "BaselineDenomList": {
        "BaselineDenom": [
          {
            "BaselineDenomUnits": "Participants",
            "BaselineDenomCountList": {
              "BaselineDenomCount": [
                {
                  "BaselineDenomCountGroupId": "BG000",
                  "BaselineDenomCountValue": "46"
                },
                {
                  "BaselineDenomCountGroupId": "BG001",
                  "BaselineDenomCountValue": "47"
                },
                {
                  "BaselineDenomCountGroupId": "BG002",
                  "BaselineDenomCountValue": "16"
                },
                {
                  "BaselineDenomCountGroupId": "BG003",
                  "BaselineDenomCountValue": "109"
                }
              ]
            }
          }
        ]
      },
      "BaselineMeasureList": {
        "BaselineMeasure": [
          {
            "BaselineMeasureTitle": "Age, Categorical",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "<=18 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Between 18 and 65 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "24"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "26"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "9"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "59"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": ">=65 years",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "22"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "21"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "50"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Age, Continuous",
            "BaselineMeasureParamType": "Median",
            "BaselineMeasureDispersionType": "Full Range",
            "BaselineMeasureUnitOfMeasure": "years",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "64",
                              "BaselineMeasurementLowerLimit": "23",
                              "BaselineMeasurementUpperLimit": "87"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "64",
                              "BaselineMeasurementLowerLimit": "29",
                              "BaselineMeasurementUpperLimit": "75"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "61",
                              "BaselineMeasurementLowerLimit": "37",
                              "BaselineMeasurementUpperLimit": "80"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "64",
                              "BaselineMeasurementLowerLimit": "23",
                              "BaselineMeasurementUpperLimit": "87"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Sex: Female, Male",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Female",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "13"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "11"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "31"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Male",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "33"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "36"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "9"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "78"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Ethnicity (NIH/OMB)",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Hispanic or Latino",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "6"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "6"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "14"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Not Hispanic or Latino",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "40"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "41"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "14"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "95"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Unknown or Not Reported",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "0"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "ECOG Performance Status",
            "BaselineMeasureDescription": "ECOG Performance Status (PS): (0) = Fully active; (1) Restricted in physically strenuous activity; (2) Ambulatory and capable of self-care; (3) Capable of limited self-care; (4) Completely disabled",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "PS=0",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "19"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "25"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "51"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "PS=1",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "27"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "22"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "9"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "58"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "PS=2",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "PS=3",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "PS=4",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "0"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "PRCC Confirmation from Central Laboratory",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "PRCC Not Confirmed",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "9"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "8"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "24"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "PRCC Confirmed",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "37"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "40"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "8"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "85"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Stage Classification",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Low",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "4"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "5"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Intermediate",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "8"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "12"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "4"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "24"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "High",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "13"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "15"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "3"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "31"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Missing",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "24"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "16"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "9"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "49"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Renal Cell Classification",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Type I PRCC",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "12"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "16"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Type II PRCC",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "25"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "38"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "6"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "69"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Unclassified PRCC",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "5"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "14"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Other",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "0"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "2"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Unknown",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "1"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "5"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "8"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "MSKCC Risk Group",
            "BaselineMeasureDescription": "Risk categories for patients were obtained from the Memorial Sloan Kettering Cancer Center (MSKCC) risk category prognostic model in advanced renal cell cancer, as follows: Favourable risk = 0 risk factors; Intermediate risk = 10 or 2 risk factors; Poor risk = 3 or more risk factors. Risk factors include: Karnofsky performance status < 80%; time from diagnosis to salvage treatment < 1 year; haemoglobin < lower limit of normal (LLN); corrected serum calcium > ULN; and serum lactate dehydrogenase > 1.5 x ULN.",
            "BaselineMeasureParamType": "Count of Participants",
            "BaselineMeasureUnitOfMeasure": "Participants",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineCategoryTitle": "Favourable Risk",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "3"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "10"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "15"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Intermediate Risk",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "28"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "14"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "7"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "49"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Poor Risk",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "3"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "5"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "2"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "10"
                            }
                          ]
                        }
                      },
                      {
                        "BaselineCategoryTitle": "Missing",
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "12"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "18"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "5"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "35"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Weight",
            "BaselineMeasureParamType": "Mean",
            "BaselineMeasureDispersionType": "Standard Deviation",
            "BaselineMeasureUnitOfMeasure": "kilograms",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "78.42",
                              "BaselineMeasurementSpread": "20.74"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "85.38",
                              "BaselineMeasurementSpread": "23.84"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "84.90",
                              "BaselineMeasurementSpread": "12.55"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "82.37",
                              "BaselineMeasurementSpread": "21.32"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "BaselineMeasureTitle": "Weight",
            "BaselineMeasureParamType": "Median",
            "BaselineMeasureDispersionType": "Full Range",
            "BaselineMeasureUnitOfMeasure": "Kg",
            "BaselineClassList": {
              "BaselineClass": [
                {
                  "BaselineCategoryList": {
                    "BaselineCategory": [
                      {
                        "BaselineMeasurementList": {
                          "BaselineMeasurement": [
                            {
                              "BaselineMeasurementGroupId": "BG000",
                              "BaselineMeasurementValue": "76.5",
                              "BaselineMeasurementLowerLimit": "42",
                              "BaselineMeasurementUpperLimit": "134"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG001",
                              "BaselineMeasurementValue": "83.5",
                              "BaselineMeasurementLowerLimit": "47",
                              "BaselineMeasurementUpperLimit": "160.6"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG002",
                              "BaselineMeasurementValue": "87.65",
                              "BaselineMeasurementLowerLimit": "59.3",
                              "BaselineMeasurementUpperLimit": "101.6"
                            },
                            {
                              "BaselineMeasurementGroupId": "BG003",
                              "BaselineMeasurementValue": "79.5",
                              "BaselineMeasurementLowerLimit": "42",
                              "BaselineMeasurementUpperLimit": "160.6"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "OutcomeMeasuresModule": {
      "OutcomeMeasureList": {
        "OutcomeMeasure": [
          {
            "OutcomeMeasureType": "Primary",
            "OutcomeMeasureTitle": "Objective Response Rate (RECIST Version 1.1)",
            "OutcomeMeasureDescription": "The primary outcome measure was Objective Response Rate (ORR), defined as the proportion of patients with either a complete response or a partial response by investigator assessment according to Response Evaluation Criteria for Solid Tumours (RECIST) v1.1.",
            "OutcomeMeasurePopulationDescription": "ORR was assessed on the efficacy analysis set, consisting of all patients with measurable disease, PRCC confirmed by a central laboratory and have received at least 1 dose of AZD6094 (n = 85).",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "Up to 12 months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Efficacy Analysis Set",
                  "OutcomeGroupDescription": "All patients with measurable disease, PRCC confirmed by central laboratory and received at least 1 dose of study medication"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "Safety Analysis Set",
                  "OutcomeGroupDescription": "All patients who have received at least 1 dose of study medication"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "85"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "109"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeCategoryTitle": "Complete Response",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Partial Response",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "3"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "8"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Stable Disease >= 5 Weeks",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "46"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "59"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Progression",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "34"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "40"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Not Evaluable",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "2"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "2"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Primary",
            "OutcomeMeasureTitle": "Objective Response Rate (RECIST Version 1.1) Stratified by c-MET Status in Efficacy Analysis Set",
            "OutcomeMeasureDescription": "The primary outcome measure was ORR, defined as the proportion of patients with either a complete response or a partial response by investigator assessment according to RECIST v1.1.",
            "OutcomeMeasurePopulationDescription": "ORR was assessed on the efficacy analysis set, consisting of all patients with measurable disease, PRCC confirmed by a central laboratory and received at least 1 dose of AZD6094 (n = 85).",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "12 Months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "c-MET Positive [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "c-MET Negative [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Total [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "37"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "40"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "8"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "85"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeCategoryTitle": "Complete Response",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Partial Response",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "3"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "3"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Stable Disease >= 5 weeks",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "23"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "19"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "4"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "46"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Progression",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "10"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "20"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "4"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "34"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Not Evaluable",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "2"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Primary",
            "OutcomeMeasureTitle": "Objective Response Rate (RECIST Version 1.1) Stratified by c-MET Status in Safety Analysis Set",
            "OutcomeMeasureDescription": "The primary outcome measure was ORR, defined as the proportion of patients with either a confirmed complete response/partial response by investigator assessment according to RECIST v1.1.",
            "OutcomeMeasurePopulationDescription": "ORR was assessed on the safety analysis set, consisting of all patients who received at least one dose of the study drug (n = 109).",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Count of Participants",
            "OutcomeMeasureUnitOfMeasure": "Participants",
            "OutcomeMeasureTimeFrame": "12 Months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "c-MET Positive [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "c-MET Negative [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG003",
                  "OutcomeGroupTitle": "Total [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "46"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "47"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "16"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG003",
                        "OutcomeDenomCountValue": "109"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeCategoryTitle": "Complete Response",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "0"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Partial Response",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "8"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "8"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Stable Disease >= 5 weeks",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "27"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "21"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "11"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "59"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Progression",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "10"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "25"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "5"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "40"
                            }
                          ]
                        }
                      },
                      {
                        "OutcomeCategoryTitle": "Not Evaluable",
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "1"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "0"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG003",
                              "OutcomeMeasurementValue": "2"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Progression Free Survival Stratified by c-MET Status in the Efficacy Analysis Set",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "95% Confidence Interval",
            "OutcomeMeasureUnitOfMeasure": "Weeks",
            "OutcomeMeasureTimeFrame": "Up to 12 months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "c-MET Positive [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "c-MET Negative [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "37"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "40"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "8"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "18.3",
                              "OutcomeMeasurementLowerLimit": "12.3",
                              "OutcomeMeasurementUpperLimit": "35.4"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "9.7",
                              "OutcomeMeasurementLowerLimit": "6.1",
                              "OutcomeMeasurementUpperLimit": "12.4"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "6.1",
                              "OutcomeMeasurementLowerLimit": "5.1",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "Due to insufficient number of events, the upper limit of the 95% CI for median PFS was not calculable."
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Overall Survival Stratified by c-MET Status in the Efficacy Analysis Set",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "95% Confidence Interval",
            "OutcomeMeasureUnitOfMeasure": "Weeks",
            "OutcomeMeasureTimeFrame": "Up to 12 months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "c-MET Positive [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "c-MET Negative [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "37"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "40"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "8"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "NA",
                              "OutcomeMeasurementLowerLimit": "34.6",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "As the sufficient number of events was not reached at the time of data cut-off, the median OS and the upper limit of the 95% CI for median OS were not calculable."
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "61.1",
                              "OutcomeMeasurementLowerLimit": "29.4",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "Due to insufficient number of events, the upper limit of the 95% CI for median OS was not calculable."
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "51.5",
                              "OutcomeMeasurementLowerLimit": "8.1",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "Due to insufficient number of events, the upper limit of the 95% CI for median OS was not calculable."
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Progression Free Survival Stratified by c-MET Status in the Safety Analysis Set",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "95% Confidence Interval",
            "OutcomeMeasureUnitOfMeasure": "Weeks",
            "OutcomeMeasureTimeFrame": "Up to 12 months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "c-MET Positive [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "c-MET Negative [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "46"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "47"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "16"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "24.7",
                              "OutcomeMeasurementLowerLimit": "17.7",
                              "OutcomeMeasurementUpperLimit": "35.4"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "6.6",
                              "OutcomeMeasurementLowerLimit": "6.1",
                              "OutcomeMeasurementUpperLimit": "11.9"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "12.1",
                              "OutcomeMeasurementLowerLimit": "6.1",
                              "OutcomeMeasurementUpperLimit": "41.9"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Overall Survival Stratified by c-MET Status in the Safety Analysis Set",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "95% Confidence Interval",
            "OutcomeMeasureUnitOfMeasure": "Weeks",
            "OutcomeMeasureTimeFrame": "Up to 12 months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "c-MET Positive [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "c-MET Negative [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "46"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "47"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "16"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "NA",
                              "OutcomeMeasurementLowerLimit": "42.9",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "As the sufficient number of events was not reached at the time of data cut-off, the median OS and the upper limit of the 95% CI for median OS were not calculable."
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "61.1",
                              "OutcomeMeasurementLowerLimit": "40.6",
                              "OutcomeMeasurementUpperLimit": "106.7"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "54.9",
                              "OutcomeMeasurementLowerLimit": "18.4",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "Due to insufficient number of events, the upper limit of the 95% CI for median OS was not calculable."
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Change From Baseline in Target Lesion Tumour Size at 12 Weeks in Efficacy Analysis Set",
            "OutcomeMeasureDescription": "12 week summary for patients in the Efficacy analysis set, by MET status. The numbers of patients analysed represent the numbers evaluable at the 12 week timepoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Mean",
            "OutcomeMeasureDispersionType": "Standard Deviation",
            "OutcomeMeasureUnitOfMeasure": "Percent change",
            "OutcomeMeasureTimeFrame": "12 Weeks (at 12 weeks timepoint)",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "c-MET Positive [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "c-MET Negative [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "22"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "14"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "1"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "-6.3",
                              "OutcomeMeasurementSpread": "21.56"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "3.4",
                              "OutcomeMeasurementSpread": "20.05"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "7.1",
                              "OutcomeMeasurementSpread": "0"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Change From Baseline in Target Lesion Tumour Size at 12 Weeks in Safety Analysis Set.",
            "OutcomeMeasureDescription": "12 week summary for patients in the Safety analysis set by MET Status. The number of patients analysed represent the number of evaluable patients at the 12 week timepoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Mean",
            "OutcomeMeasureDispersionType": "Standard Deviation",
            "OutcomeMeasureUnitOfMeasure": "Percent change",
            "OutcomeMeasureTimeFrame": "12 Weeks (at 12 week timepoint)",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "c-MET Positive [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants tested for the presence of c-MET mutations"
                },
                {
                  "OutcomeGroupId": "OG001",
                  "OutcomeGroupTitle": "c-MET Negative [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                },
                {
                  "OutcomeGroupId": "OG002",
                  "OutcomeGroupTitle": "c-MET Status Unknown [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All participants were tested for the presence of c-MET mutations."
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "30"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG001",
                        "OutcomeDenomCountValue": "16"
                      },
                      {
                        "OutcomeDenomCountGroupId": "OG002",
                        "OutcomeDenomCountValue": "6"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "-10.9",
                              "OutcomeMeasurementSpread": "21.39"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG001",
                              "OutcomeMeasurementValue": "4.3",
                              "OutcomeMeasurementSpread": "18.96"
                            },
                            {
                              "OutcomeMeasurementGroupId": "OG002",
                              "OutcomeMeasurementValue": "5.1",
                              "OutcomeMeasurementSpread": "17.41"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Duration of Response",
            "OutcomeMeasureDescription": "Duration of Response is the time from the first documentation of confirmed complete response/partial response until the date of progression, or death in the absence of progression. There were 8 responders: one of whom subsequently progressed or died and seven of whom were still classified as responders at the time of data cut-off and were therefore censored. It was not possible to determine a median or 75th percentile.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "Inter-Quartile Range",
            "OutcomeMeasureUnitOfMeasure": "Weeks",
            "OutcomeMeasureTimeFrame": "Up to 12 months",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Safety Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients who have received at least 1 dose of study medication"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "109"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "NA",
                              "OutcomeMeasurementLowerLimit": "18.1",
                              "OutcomeMeasurementUpperLimit": "NA",
                              "OutcomeMeasurementComment": "The median DoR and 75th percentile for DoR were not calculable within the timeframe of this study."
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Peak Plasma Concentration of AZD6094 Following Single Dose",
            "OutcomeMeasureDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Geometric Mean",
            "OutcomeMeasureDispersionType": "Geometric Coefficient of Variation",
            "OutcomeMeasureUnitOfMeasure": "ng/mL",
            "OutcomeMeasureTimeFrame": "24 Hours",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Pharmacokinetic Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients that received at least one dose of study medication and had evaluable PK data"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "53"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "3038.8984",
                              "OutcomeMeasurementSpread": "44.4184"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Time to Peak Plasma Concentration of AZD6094 After Single Dose",
            "OutcomeMeasureDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Median",
            "OutcomeMeasureDispersionType": "Full Range",
            "OutcomeMeasureUnitOfMeasure": "Hours",
            "OutcomeMeasureTimeFrame": "24 Hours",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Pharmacokinetic Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients that received at least one dose of study medication and had evaluable PK data"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "53"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "2.0",
                              "OutcomeMeasurementLowerLimit": "0.5",
                              "OutcomeMeasurementUpperLimit": "8.0"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Apparent Volume of Distribution of AZD6094 Following Single Dose",
            "OutcomeMeasureDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Mean",
            "OutcomeMeasureDispersionType": "Standard Deviation",
            "OutcomeMeasureUnitOfMeasure": "Liters",
            "OutcomeMeasureTimeFrame": "24 Hours",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Pharmacokinetic Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients that received at least one dose of study medication and had evaluable PK data"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "19"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "137.4237",
                              "OutcomeMeasurementSpread": "36.5971"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Area Under Plasma Concentration Time Curve for AZD6094 After Single Dose",
            "OutcomeMeasureDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Geometric Mean",
            "OutcomeMeasureDispersionType": "Geometric Coefficient of Variation",
            "OutcomeMeasureUnitOfMeasure": "h*ng/mL",
            "OutcomeMeasureTimeFrame": "24 Hours",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Pharmacokinetic Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients that received at least one dose of study medication and had evaluable PK data"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "19"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "13144.7381",
                              "OutcomeMeasurementSpread": "36.4328"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Area Under Plasma Concentration Time Curve for AZD6094 After Single Dose (Time Zero to Last Measurement)",
            "OutcomeMeasureDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Geometric Mean",
            "OutcomeMeasureDispersionType": "Geometric Coefficient of Variation",
            "OutcomeMeasureUnitOfMeasure": "h*ng/mL",
            "OutcomeMeasureTimeFrame": "24 Hours",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Pharmacokinetic Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients that received at least one dose of study medication and had evaluable PK data"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "53"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "13214.2441",
                              "OutcomeMeasurementSpread": "46.4616"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Apparent Total Clearance of AZD6094 From Plasma After Single Dose",
            "OutcomeMeasureDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Mean",
            "OutcomeMeasureDispersionType": "Standard Deviation",
            "OutcomeMeasureUnitOfMeasure": "L/hour",
            "OutcomeMeasureTimeFrame": "24 Hours",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Pharmacokinetic Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients that received at least one dose of study medication and had evaluable PK data"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "19"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "48.4938",
                              "OutcomeMeasurementSpread": "17.3386"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Mean Residence Time of AZD6094 After Single Dose",
            "OutcomeMeasureDescription": "The number of patients analysed represent the number of evaluable PK parameters for this endpoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Mean",
            "OutcomeMeasureDispersionType": "Standard Deviation",
            "OutcomeMeasureUnitOfMeasure": "Hours",
            "OutcomeMeasureTimeFrame": "24 Hours",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Pharmacokinetic Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients that received at least one dose of study medication and had evaluable PK data"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "19"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "3.9837",
                              "OutcomeMeasurementSpread": "0.4813"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          },
          {
            "OutcomeMeasureType": "Secondary",
            "OutcomeMeasureTitle": "Elimination Half-Life of AZD6094 After Single Dose",
            "OutcomeMeasureDescription": "The number of patients analysed represent the number of patients with evaluable PK parameters for this endpoint.",
            "OutcomeMeasureReportingStatus": "Posted",
            "OutcomeMeasureParamType": "Mean",
            "OutcomeMeasureDispersionType": "Standard Deviation",
            "OutcomeMeasureUnitOfMeasure": "Hours",
            "OutcomeMeasureTimeFrame": "24 Hours",
            "OutcomeGroupList": {
              "OutcomeGroup": [
                {
                  "OutcomeGroupId": "OG000",
                  "OutcomeGroupTitle": "Pharmacokinetic Analysis Set [600mg AZD6094 po]",
                  "OutcomeGroupDescription": "All patients that received at least one dose of study medication and had evaluable PK data"
                }
              ]
            },
            "OutcomeDenomList": {
              "OutcomeDenom": [
                {
                  "OutcomeDenomUnits": "Participants",
                  "OutcomeDenomCountList": {
                    "OutcomeDenomCount": [
                      {
                        "OutcomeDenomCountGroupId": "OG000",
                        "OutcomeDenomCountValue": "19"
                      }
                    ]
                  }
                }
              ]
            },
            "OutcomeClassList": {
              "OutcomeClass": [
                {
                  "OutcomeCategoryList": {
                    "OutcomeCategory": [
                      {
                        "OutcomeMeasurementList": {
                          "OutcomeMeasurement": [
                            {
                              "OutcomeMeasurementGroupId": "OG000",
                              "OutcomeMeasurementValue": "2.0499",
                              "OutcomeMeasurementSpread": "0.3820"
                            }
                          ]
                        }
                      }
                    ]
                  }
                }
              ]
            }
          }
        ]
      }
    },
    "AdverseEventsModule": {
      "EventsFrequencyThreshold": "5",
      "EventsTimeFrame": "Up to 12 months",
      "EventGroupList": {
        "EventGroup": [
          {
            "EventGroupId": "EG000",
            "EventGroupTitle": "AZD6094 600 mg Per Day Orally",
            "EventGroupDescription": "All patients who received at least one dose of study medication",
            "EventGroupDeathsNumAffected": "57",
            "EventGroupDeathsNumAtRisk": "109",
            "EventGroupSeriousNumAffected": "27",
            "EventGroupSeriousNumAtRisk": "109",
            "EventGroupOtherNumAffected": "107",
            "EventGroupOtherNumAtRisk": "109"
          }
        ]
      },
      "SeriousEventList": {
        "SeriousEvent": [
          {
            "SeriousEventTerm": "Abdominal incarcerated hernia",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Abdominal pain",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Acute kidney injury",
            "SeriousEventOrganSystem": "Renal and urinary disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "4",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Adrenal insufficiency",
            "SeriousEventOrganSystem": "Endocrine disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Anaemia",
            "SeriousEventOrganSystem": "Blood and lymphatic system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "3",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Ascites",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Cellulitis",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Cholecystitis",
            "SeriousEventOrganSystem": "Hepatobiliary disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Constipation",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "2",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Dehydration",
            "SeriousEventOrganSystem": "Metabolism and nutrition disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Dyspnoea",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Hepatic encephalopathy",
            "SeriousEventOrganSystem": "Nervous system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Hyperkalemia",
            "SeriousEventOrganSystem": "Metabolism and nutrition disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Hyponatraemia",
            "SeriousEventOrganSystem": "Metabolism and nutrition disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Lung Infection",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Nausea",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pain",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pericarditis",
            "SeriousEventOrganSystem": "Cardiac disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pleural effusion",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pneumonia",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pneumonitis",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Sepsis",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Transaminases increased",
            "SeriousEventOrganSystem": "Investigations",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Urinary tract infection",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Vomiting",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Wound infection",
            "SeriousEventOrganSystem": "Infections and infestations",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Drug-induced Liver Injury",
            "SeriousEventOrganSystem": "Hepatobiliary disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Pulmonary Embolism",
            "SeriousEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Loss of Consciousness",
            "SeriousEventOrganSystem": "Nervous system disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Oedema",
            "SeriousEventOrganSystem": "General disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Myocardial Infaction",
            "SeriousEventOrganSystem": "Cardiac disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Small intestinal obstruction",
            "SeriousEventOrganSystem": "Gastrointestinal disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Flank pain",
            "SeriousEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Rectal cancer",
            "SeriousEventOrganSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Confusional state",
            "SeriousEventOrganSystem": "Psychiatric disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "SeriousEventTerm": "Embolism",
            "SeriousEventOrganSystem": "Vascular disorders",
            "SeriousEventSourceVocabulary": "MedDRA 18.1",
            "SeriousEventAssessmentType": "Non-systematic Assessment",
            "SeriousEventStatsList": {
              "SeriousEventStats": [
                {
                  "SeriousEventStatsGroupId": "EG000",
                  "SeriousEventStatsNumAffected": "1",
                  "SeriousEventStatsNumAtRisk": "109"
                }
              ]
            }
          }
        ]
      },
      "OtherEventList": {
        "OtherEvent": [
          {
            "OtherEventTerm": "Anaemia",
            "OtherEventOrganSystem": "Blood and lymphatic system disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "17",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Nausea",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "56",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Vomiting",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "34",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Constipation",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "29",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Diarrhoea",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "18",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Abdominal pain",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Abdominal distension",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Stomatitis",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Fatigue",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "49",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Peripheral oedema",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "35",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Asthenia",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Oedema",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Chest pain",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Mucosal inflammation",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood creatinine increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "18",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Aspartate aminotransferase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "15",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Weight decreased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "14",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Alanine aminotransferase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "12",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Weight increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Blood alklaine phosphatase increased",
            "OtherEventOrganSystem": "Investigations",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Decreased appetite",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "25",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypoalbuminaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "13",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperglycaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyperkalaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hyponatremia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Back pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "16",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Arthalgia",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "13",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Musculoskeletal chest pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pain in extremity",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "11",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Flank pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dizziness",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "11",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dysgeusia",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "9",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Headache",
            "OtherEventOrganSystem": "Nervous system disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "8",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Proteinuria",
            "OtherEventOrganSystem": "Renal and urinary disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "11",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dyspnoea",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "16",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Cough",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "16",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Dyspnoea exertional",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "11",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Musculoskeletal pain",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "10",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypomagnesaemia",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Muscle spasm",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "7",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Myalgia",
            "OtherEventOrganSystem": "Musculoskeletal and connective tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "6",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pleural Effusion",
            "OtherEventOrganSystem": "Respiratory, thoracic and mediastinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pain",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Chills",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pyrexia",
            "OtherEventOrganSystem": "General disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Fluid retention",
            "OtherEventOrganSystem": "Metabolism and nutrition disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Ascites",
            "OtherEventOrganSystem": "Gastrointestinal disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Insomnia",
            "OtherEventOrganSystem": "Psychiatric disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Pruritus",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Rash maculo-papular",
            "OtherEventOrganSystem": "Skin and subcutaneous tissue disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypertension",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          },
          {
            "OtherEventTerm": "Hypotension",
            "OtherEventOrganSystem": "Vascular disorders",
            "OtherEventSourceVocabulary": "MedDRA 18.1",
            "OtherEventAssessmentType": "Non-systematic Assessment",
            "OtherEventStatsList": {
              "OtherEventStats": [
                {
                  "OtherEventStatsGroupId": "EG000",
                  "OtherEventStatsNumAffected": "5",
                  "OtherEventStatsNumAtRisk": "109"
                }
              ]
            }
          }
        ]
      }
    },
    "MoreInfoModule": {
      "CertainAgreement": {
        "AgreementPISponsorEmployee": "No",
        "AgreementRestrictiveAgreement": "No"
      },
      "PointOfContact": {
        "PointOfContactTitle": "Senior Medical Director, Savolitinib",
        "PointOfContactOrganization": "AstraZeneca",
        "PointOfContactEMail": "ClinicalTrialTransparency@astrazeneca.com"
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000002292",
            "ConditionMeshTerm": "Carcinoma, Renal Cell"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000002277",
            "ConditionAncestorTerm": "Carcinoma"
          },
          {
            "ConditionAncestorId": "D000009375",
            "ConditionAncestorTerm": "Neoplasms, Glandular and Epithelial"
          },
          {
            "ConditionAncestorId": "D000009370",
            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          },
          {
            "ConditionAncestorId": "D000000230",
            "ConditionAncestorTerm": "Adenocarcinoma"
          },
          {
            "ConditionAncestorId": "D000007680",
            "ConditionAncestorTerm": "Kidney Neoplasms"
          },
          {
            "ConditionAncestorId": "D000014571",
            "ConditionAncestorTerm": "Urologic Neoplasms"
          },
          {
            "ConditionAncestorId": "D000014565",
            "ConditionAncestorTerm": "Urogenital Neoplasms"
          },
          {
            "ConditionAncestorId": "D000009371",
            "ConditionAncestorTerm": "Neoplasms by Site"
          },
          {
            "ConditionAncestorId": "D000007674",
            "ConditionAncestorTerm": "Kidney Diseases"
          },
          {
            "ConditionAncestorId": "D000014570",
            "ConditionAncestorTerm": "Urologic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M4686",
            "ConditionBrowseLeafName": "Carcinoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4700",
            "ConditionBrowseLeafName": "Carcinoma, Renal Cell",
            "ConditionBrowseLeafAsFound": "Papillary Renal Cell Carcinoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11472",
            "ConditionBrowseLeafName": "Neoplasms, Glandular and Epithelial",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11467",
            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M2737",
            "ConditionBrowseLeafName": "Adenocarcinoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9855",
            "ConditionBrowseLeafName": "Kidney Neoplasms",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16472",
            "ConditionBrowseLeafName": "Urologic Neoplasms",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16467",
            "ConditionBrowseLeafName": "Urogenital Neoplasms",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9850",
            "ConditionBrowseLeafName": "Kidney Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16471",
            "ConditionBrowseLeafName": "Urologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4906",
            "ConditionBrowseLeafName": "Renal Cell Carcinoma",
            "ConditionBrowseLeafAsFound": "Renal Cell Carcinoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T1341",
            "ConditionBrowseLeafName": "Clear Cell Renal Cell Carcinoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4400",
            "ConditionBrowseLeafName": "Papillary Renal Cell Carcinoma",
            "ConditionBrowseLeafAsFound": "Papillary Renal Cell Carcinoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T1193",
            "ConditionBrowseLeafName": "Chromophil Renal Cell Carcinoma",
            "ConditionBrowseLeafAsFound": "Papillary Renal Cell Cancer",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}